Gene · 8473
Papers4,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Galectin-3: Integrator of Signaling via Hexosamine Flux. | Biomolecules | 2025 | 40723900 | PubTator, text mining | PubMed |
| Profiling HIV1-host protein-protein interaction networks in patient-derived exosome proteins: impact on pathophysiology and innate immune pathways. | Virol J | 2025 | 40722180 | PubTator, text mining | PubMed |
| O-GlcNAcylation at S659 enhances SARS-CoV-2 spike protein stability and pseudoparticle packaging efficiency. | Microbiol Spectr | 2025 | 40719472 | PubTator, text mining | PubMed |
| Editorial: Advancements in hematopoietic stem cell proliferation and self-renewal maintenance. | Front Cell Dev Biol | 2025 | 40692753 | PubTator, text mining | PubMed |
| OSMI-4-based PROTACs do not influence O-GlcNAc transferase and O-GlcNAcylation levels in cells. | RSC Adv | 2025 | 40686638 | PubTator, text mining | PubMed |
| O‑GlcNAcylation as an emerging molecular target for cholangiocarcinoma therapy (Review). | Oncol Rep | 2025 | 40682838 | PubTator, text mining | PubMed |
| A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis. | Nat Cell Biol | 2025 | 40681752 | PubTator, text mining | PubMed |
| Emerging Roles of Protein O-GlcNAcylation in Bone Remodeling: New Insights Into Osteoporosis. | Acta Physiol (Oxf) | 2025 | 40665904 | PubTator, text mining | PubMed |
| Interplay between O-GlcNAcylation and 5-FU response in colorectal cancer: Novel insights from an examination of primary and metastatic cell lines. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40664266 | PubTator, text mining | PubMed |
| Dynamic regulation of the COPII interactome and collagen trafficking by site-specific glycosylation of Sec24D. | bioRxiv | 2025 | 40661455 | PubTator, text mining | PubMed |
| PRIME, a temperature-guided language model revolutionizes protein engineering. | Acta Pharm Sin B | 2025 | 40654349 | PubTator, text mining | PubMed |
| Immunohistochemical Study on O-GlcNAcylation in Diabetic Pathologies: Molecular Mechanisms and Implications. | Acta Histochem Cytochem | 2025 | 40630794 | PubTator, text mining | PubMed |
| Application and mechanisms of targeting BRD4 in osteosarcoma. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 40628510 | PubTator, text mining | PubMed |
| HIF-O-Glcnac Axis - Implications for Breast Cancer Metastasis. | Cell Physiol Biochem | 2025 | 40598910 | PubTator, text mining | PubMed |
| O-GlcNAcylation of the intellectual disability protein DDX3X exerts proteostatic cell cycle control. | Open Biol | 2025 | 40592469 | PubTator, text mining | PubMed |
| Increased O-GlcNAcylation in Leukocytes from Overweight Pediatric Subjects: A Pilot Study. | Int J Mol Sci | 2025 | 40565129 | PubTator, text mining | PubMed |
| Integrated transcriptome analysis and combinatorial machine learning to construct a homeostatic model of acetylation for ccRCC and validate the key gene GCNT4. | Cancer Cell Int | 2025 | 40563096 | PubTator, text mining | PubMed |
| YEATS2 O-GlcNAcylation promotes chromatin association of the ATAC complex and lung cancer tumorigenesis. | J Biol Chem | 2025 | 40541806 | PubTator, text mining | PubMed |
| Recent Progress of Small-molecule Inhibitors of O-GlcNAcase for Alzheimer's Disease. | Mini Rev Med Chem | 2025 | 40539342 | PubTator, text mining | PubMed |
| Targeted O-GlcNAcylation of CK2α Triggers Its Ubiquitin-Proteasome Degradation and Alters Downstream Phosphorylation. | ACS Chem Biol | 2025 | 40521680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8473/papers?page=13